G. Quack

4.6k total citations · 1 hit paper
49 papers, 3.9k citations indexed

About

G. Quack is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, G. Quack has authored 49 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cellular and Molecular Neuroscience, 22 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in G. Quack's work include Neuroscience and Neuropharmacology Research (28 papers), Ion channel regulation and function (12 papers) and Epilepsy research and treatment (9 papers). G. Quack is often cited by papers focused on Neuroscience and Neuropharmacology Research (28 papers), Ion channel regulation and function (12 papers) and Epilepsy research and treatment (9 papers). G. Quack collaborates with scholars based in Germany, Poland and Spain. G. Quack's co-authors include Wojciech Danysz, Chris G. Parsons, Johannes Kornhuber, Werner Schmidt, Sabine Hartmann, X.A. Alvarez, Ramón Cacabelos, José Javier Miguel-Hidalgo, Paweł Krząścik and Wojciech Kostowski and has published in prestigious journals such as Hepatology, Brain Research and Neuroscience & Biobehavioral Reviews.

In The Last Decade

G. Quack

48 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data

1999 738 citations Chris G. Parsons, Wojciech Danysz et al. Neuropharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Quack Germany	27	2.2k	1.4k	778	712	446	49	3.9k
Joann Labruyere United States	28	2.9k 1.3×	1.7k 1.3×	431 0.6×	484 0.7×	402 0.9×	33	5.2k
Anthony S. Basile United States	45	2.8k 1.3×	2.4k 1.8×	718 0.9×	626 0.9×	386 0.9×	148	6.0k
P. C. Waldmeier Switzerland	40	2.8k 1.3×	2.3k 1.7×	556 0.7×	562 0.8×	608 1.4×	155	5.2k
Shigeru Okuyama Japan	37	3.2k 1.4×	2.9k 2.2×	722 0.9×	538 0.8×	406 0.9×	148	6.4k
Robert E. Davis United States	35	1.4k 0.6×	2.4k 1.8×	846 1.1×	617 0.9×	894 2.0×	129	4.6k
Michel Maître France	42	3.6k 1.7×	1.7k 1.3×	1.2k 1.6×	373 0.5×	416 0.9×	165	5.8k
Hoau-Yan Wang United States	30	1.6k 0.7×	2.0k 1.5×	1.9k 2.4×	764 1.1×	397 0.9×	50	4.6k
Aaron Janowsky United States	43	3.5k 1.6×	2.6k 1.9×	477 0.6×	649 0.9×	438 1.0×	129	5.5k
Lee A. Phebus United States	33	1.6k 0.7×	1.0k 0.8×	638 0.8×	734 1.0×	637 1.4×	53	3.6k
Ennio Ongini Italy	50	1.8k 0.8×	2.7k 2.0×	1.2k 1.6×	720 1.0×	303 0.7×	138	6.8k

Countries citing papers authored by G. Quack

Since Specialization

Citations

This map shows the geographic impact of G. Quack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Quack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Quack more than expected).

Fields of papers citing papers by G. Quack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Quack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Quack. The network helps show where G. Quack may publish in the future.

Co-authorship network of co-authors of G. Quack

This figure shows the co-authorship network connecting the top 25 collaborators of G. Quack. A scholar is included among the top collaborators of G. Quack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Quack. G. Quack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miguel-Hidalgo, José Javier, X.A. Alvarez, Ramón Cacabelos, & G. Quack. (2002). Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40). Brain Research. 958(1). 210–221. 222 indexed citations

Rose, Christopher F., Adrianna Michalak, Kakulavarapu V. Rama Rao, et al.. (1999). L -Ornithine- L -aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. Hepatology. 30(3). 636–640. 124 indexed citations

Hanke, Sybille, Joachim Kamenz, Rainer Voisard, et al.. (1998). Effect of the antioxidant Nicanartine on the proliferative and inflammatory response after experimental balloon angioplasty. Coronary Artery Disease. 9(12). 831–838. 4 indexed citations

Karcz‐Kubicha, Marzena, G. Quack, & Wojciech Danysz. (1998). Amantadine attenuates response alterations resulting from repetitive L-DOPA treatment in rats. Journal of Neural Transmission. 105(10-12). 1229–1236. 6 indexed citations

Parsons, Chris G., et al.. (1998). Modulation of NMDA receptors by glycine ? introduction to some basic aspects and recent developments. Amino Acids. 14(1-3). 207–216. 51 indexed citations

Scholtissek, Christoph, G. Quack, Hans‐Dieter Klenk, & Robert G. Webster. (1998). How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Research. 37(2). 83–95. 112 indexed citations

Lupp, Amelie, et al.. (1998). Investigation on possible antioxidative properties of the NMDA-receptor antagonists ketamine, memantine, and amantadine in comparison to nicanartine in vitro. Experimental and Toxicologic Pathology. 50(4-6). 501–506. 16 indexed citations

Danysz, Wojciech, Chris G. Parsons, Piotr Popik, et al.. (1998). GlycineB antagonists as potential therapeutic agents. Amino Acids. 14(1-3). 235–239. 39 indexed citations

Vogels, Birgit A. P. M., M.A.W. Maas, Joost Daalhuisen, G. Quack, & Robert A.F.M. Chamuleau. (1997). Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology. 25(4). 820–827. 116 indexed citations

10.

Zajączkowski, Wojciech M., G. Quack, & Wojciech Danysz. (1996). Infusion of (+)-MK-801 and memantine — contrasting effects on radial maze learning in rats with entorhinal cortex lesion. European Journal of Pharmacology. 296(3). 239–246. 101 indexed citations

11.

Parsons, Chris G., G. Quack, I. Bresink, et al.. (1995). Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology. 34(10). 1239–1258. 268 indexed citations

12.

Kornhuber, Johannes & G. Quack. (1995). Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man. Neuroscience Letters. 195(2). 137–139. 136 indexed citations

13.

Bocos, Carlos, et al.. (1995). Effect of etofibrate on bile production in the normolipidemic rat. General Pharmacology The Vascular System. 26(3). 537–542. 2 indexed citations

14.

Hilgier, Wojciech, et al.. (1994). Increase of the brain uptake index for L-ornithine in rats with hepatic encephalopathy. Neuroreport. 5(6). 671–673. 21 indexed citations

15.

Danysz, Wojciech, Matthias Gossel, Wojciech M. Zajączkowski, David L. Dill, & G. Quack. (1994). Are NMDA antagonistic properties relevant for antiparkinsonianlike activity in rats?—Case of amantadine and memantine. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 7(3). 155–166. 66 indexed citations

16.

Skuza, G, et al.. (1994). Memantine, amantadine, and L-deprenyl potentiate the action of L-DOPA in monoamine-depleted rats. Journal of Neural Transmission. 98(1). 57–67. 39 indexed citations

17.

Danysz, Wojciech, et al.. (1993). Potential Antidepressive Properties of Amantadine, Memantine and Bifemelane. Pharmacology & Toxicology. 72(6). 394–397. 126 indexed citations

18.

Osborne, Neville N. & G. Quack. (1992). Memantine stimulates inositol phosphates production in neurones and nullifies N- destruction of retinal neurones. Neurochemistry International. 21(3). 329–336. 28 indexed citations

19.

Fabiani, Emma De, Maurizio Crestani, Marina Del Puppo, et al.. (1989). The effect of etofibrate on cholesterol and bile acid metabolism in the hamster. Pharmacological Research. 21(5). 567–576. 9 indexed citations

20.

Herrera, Emílio, Miguel A. Lasunción, Mario Castro, et al.. (1988). Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 963(1). 42–52. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact